View in EDS HTML Full Text PDF Full Text

Real‐world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis.

Saved in:
Bibliographic Details
Title: Real‐world data confirm elexacftor/tezacaftor/ivacaftor modulators halves sweat chloride concentration in eligible people with cystic fibrosis.
Authors: Bryrup, Thomas1,2 (AUTHOR) thomas.bryrup@regionh.dk, Faurholt‐Jepsen, Daniel1,2 (AUTHOR), Pressler, Tacjana1,2,3 (AUTHOR), Henriksen, Esben Herborg1,2 (AUTHOR), Leo‐Hansen, Christian1,2 (AUTHOR), Nielsen, Bibi Uhre1,2 (AUTHOR), Højte, Christine1,2,3 (AUTHOR), Mathiesen, Inger Hee Mabuza1,2 (AUTHOR), Katzenstein, Terese L.1,2 (AUTHOR), Jeppesen, Majbritt1,4 (AUTHOR), Jensen‐Fangel, Søren1,4 (AUTHOR), Olesen, Hanne Vebert1,5 (AUTHOR), Skov, Marianne1,3 (AUTHOR), Qvist, Tavs1,2 (AUTHOR), Olsen, Mette Frahm1,2,6 (AUTHOR)
Source: APMIS. Oct2024, Vol. 132 Issue 10, p728-733. 6p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09034641
DOI:10.1111/apm.13453